Elanco Animal Health (ELAN) Gross Profit (2017 - 2026)

Elanco Animal Health has disclosed Gross Profit across 10 years of filings, most recently posting $785.0 million for Q1 2026.

• Gross Profit for Q1 2026 came in at $785.0 million, up 14.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.7 billion (up 10.86% YoY), and the FY2025 annual result was $2.6 billion, up 6.44% from the prior year.
• Gross Profit came in at $785.0 million for Q1 2026 at Elanco Animal Health, up from $589.0 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $785.0 million in Q1 2026 to a low of $519.0 million in Q4 2023.
• The 5-year median for Gross Profit is $623.0 million (2023), against an average of $635.2 million.
• Across the five-year window, Gross Profit fell 11.92% in 2022 and advanced 14.77% in 2026, its largest moves.
• Elanco Animal Health's Gross Profit stood at $537.0 million in 2022, then dropped by 3.35% to $519.0 million in 2023, then changed by 0.0% to $519.0 million in 2024, then advanced by 13.49% to $589.0 million in 2025, then jumped by 33.28% to $785.0 million in 2026.
• The last three Gross Profit figures came in at $785.0 million (Q1 2026), $589.0 million (Q4 2025), and $607.0 million (Q3 2025), per Business Quant data.